# K122247: Lidcorapid V2 Monitor

- Pathway: 510(k) (Traditional)
- Applicant: Lidco, Ltd.
- Decided: Mar 20, 2013 after 236 days
- Product code: DXG (Computer, Diagnostic, Pre-Programmed, Single-Function)
- Device class: 2
- Regulation: 21 CFR 870.1435
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
2 later devices descend from it; 1 cites it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Most influential descendants
- K152006: Cogent Hemodynamic Monitoring System (2016), 1 descendant of its own
- K232048: Cogent™ Hemodynamic Monitoring System; Cogent™ HMS (2023), 0 descendants of its own

## Indications for use
The LiDOarapid V2 Monitor is intended for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use for: 1. The mteasurerbentof blood pressure, cardiac output and associated. hemodyniaric parameters in adult patients. 2. When connected to the 815 Module: monitoringthe.state of the brain by data acquisition of EEG signals and may be used as an aid in monitoring the effects of certain anesthetic agents: Use of BIS monitoring to help guideahesthetic administration may be associated with the reduction of the incidence of awareness with recall in adults during general anesthesia and sedation

Source page: https://510kreport.com/device/K122247
Methodology: https://510kreport.com/methodology